Compounds and anti-tumor NQO1 substrates

Paul J Hergenrother (Inventor), David A Boothman (Inventor), Joseph S Bair (Inventor), Rahul Palchaudhuri (Inventor), Elizabeth I Parkinson (Inventor)

Research output: Patent

Abstract

Compounds of Formula (I) can be selectively lethal toward a variety of different cancer cell types. The compounds are useful for the management, treatment, control, or adjunct treatment of diseases, where the selective lethality is beneficial in chemotherapeutic therapy.
Original languageEnglish (US)
U.S. patent number9611266
Filing date1/11/16
StatePublished - Apr 4 2017

Fingerprint

Dive into the research topics of 'Compounds and anti-tumor NQO1 substrates'. Together they form a unique fingerprint.

Cite this